202 related articles for article (PubMed ID: 34762526)
1. Development of metabolic and contractile alterations in development of cancer cachexia in female tumor-bearing mice.
Lim S; Deaver JW; Rosa-Caldwell ME; Haynie WS; Morena da Silva F; Cabrera AR; Schrems ER; Saling LW; Jansen LT; Dunlap KR; Wiggs MP; Washington TA; Greene NP
J Appl Physiol (1985); 2022 Jan; 132(1):58-72. PubMed ID: 34762526
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
3. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice.
Blackwell TA; Cervenka I; Khatri B; Brown JL; Rosa-Caldwell ME; Lee DE; Perry RA; Brown LA; Haynie WS; Wiggs MP; Bottje WG; Washington TA; Kong BC; Ruas JL; Greene NP
Physiol Genomics; 2018 Dec; 50(12):1071-1082. PubMed ID: 30289747
[TBL] [Abstract][Full Text] [Related]
5. The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.
Morena da Silva F; Lim S; Cabrera AR; Schrems ER; Jones RG; Rosa-Caldwell ME; Washington TA; Murach KA; Greene NP
BMC Genomics; 2023 Jul; 24(1):374. PubMed ID: 37403010
[TBL] [Abstract][Full Text] [Related]
6. Development of skeletal muscle fibrosis in a rodent model of cancer cachexia.
Washington TA; Schrems ER; Haynie WS; Rosa-Caldwell ME; Brown JL; Saling L; Lim S; Perry RA; Brown LA; Lee DE; Greene NP
Cell Biochem Funct; 2023 Jun; 41(4):478-489. PubMed ID: 37150891
[TBL] [Abstract][Full Text] [Related]
7. PGC-1α overexpression is not sufficient to mitigate cancer cachexia in either male or female mice.
Morena da Silva F; Rosa-Caldwell ME; Schrems ER; Martinez L; Amos MG; Lim S; Cabrera AR; Brown JL; Washington TA; Greene NP
Appl Physiol Nutr Metab; 2022 Sep; 47(9):933-948. PubMed ID: 35700525
[TBL] [Abstract][Full Text] [Related]
8. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
9. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
[TBL] [Abstract][Full Text] [Related]
10. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
[TBL] [Abstract][Full Text] [Related]
11. Cancer cachexia-induced muscle atrophy: evidence for alterations in microRNAs important for muscle size.
Lee DE; Brown JL; Rosa-Caldwell ME; Blackwell TA; Perry RA; Brown LA; Khatri B; Seo D; Bottje WG; Washington TA; Wiggs MP; Kong BW; Greene NP
Physiol Genomics; 2017 May; 49(5):253-260. PubMed ID: 28341621
[TBL] [Abstract][Full Text] [Related]
12. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
13. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
14. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
15. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
16. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
17. Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.
Li B; Wan L; Li Y; Yu Q; Chen P; Gan R; Yang Q; Han Y; Guo C
Tumour Biol; 2014 Dec; 35(12):12415-25. PubMed ID: 25195133
[TBL] [Abstract][Full Text] [Related]
18. Reduced sucrose nonfermenting AMPK-related kinase (SNARK) activity aggravates cancer-induced skeletal muscle wasting.
Alves CRR; MacDonald TL; Nigro P; Pathak P; Hirshman MF; Goodyear LJ; Lessard SJ
Biomed Pharmacother; 2019 Sep; 117():109197. PubMed ID: 31387190
[TBL] [Abstract][Full Text] [Related]
19. Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.
Roberts BM; Frye GS; Ahn B; Ferreira LF; Judge AR
Biochem Biophys Res Commun; 2013 Jun; 435(3):488-92. PubMed ID: 23673294
[TBL] [Abstract][Full Text] [Related]
20. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
